{
  "id": "agdi2",
  "display_name": "Alpha-Glucosidase Inhibitors (SHHS2)",
  "description": "Participant taking ALPHA-GLUCOSIDASE INHIBITORS within two weeks of the SHHS2 visit.  All medications were recorded during the interview, and medication information was later categorized by physician review.",
  "type": "choices",
  "domain": "noyes01",
  "labels": [
    "AGDI2",
    "diabetes"
  ],
  "forms": [
  "shhs2_medication_form"
  ]
}
